# Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

> **NCT00086502** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 353 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Comparator: Sitagliptin
- **DRUG:** Comparator: Placebo
- **DRUG:** Comparator: Pioglitazone
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00086502
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2016-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086502, "Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00086502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*